Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2006)
Effusions in the presence of cancer
Jo‐Heon Kim, Ga-Eon Kim, Y. Choi, J. Lee, Jae Lee, J. Nam, Chan Choi (2009)
Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocksDiagnostic Cytopathology, 37
Suk‐Jin Choi, Y. Choi, L. Kim, In-Suh Park, J. Han, Joon-Mee Kim, Y. Chu (2014)
Preparation of Compact Agarose Cell Blocks from the Residues of Liquid-Based Cytology SamplesKorean Journal of Pathology, 48
P. Morin (2005)
Claudin proteins in human cancer: promising new targets for diagnosis and therapy.Cancer research, 65 21
S. Lonardi, C. Manera, R. Marucci, A. Santoro, L. Lorenzi, F. Facchetti (2011)
Usefulness of Claudin 4 in the cytological diagnosis of serosal effusionsDiagnostic Cytopathology, 39
V. Jo, E. Cibas, G. Pinkus (2014)
Claudin‐4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytologyCancer Cytopathology, 122
F. Facchetti, S. Lonardi, F. Gentili, L. Bercich, M. Falchetti, R. Tardanico, C. Baronchelli, L. Lucini, A. Santin, B. Murer (2007)
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusionsVirchows Archiv, 451
Sambit Mohanty, Pranab Dey (2003)
Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic reviewPostgraduate Medical Journal, 79
(2006)
Effusions in the presence of cancer; in Koss LG, Melamed MR (eds): Koss’ Diagnostic Cytology and Its Histopathological Bases
S. Tsukita, M. Furuse, M. Itoh (2001)
Multifunctional strands in tight junctionsNature Reviews Molecular Cell Biology, 2
Fauzia Mohamed, N. Vincent, M. Cottier, M. Péoc'h, Y. Merrouche, B. Patouillard, S. Paul, C. Genin (2010)
Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expressionBiomarkers, 15
N. Ordóñez (2013)
Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomasModern Pathology, 26
Y. Soini, V. Kinnula, K. Kahlos, P. Pääkkö (2006)
Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleuraJournal of Clinical Pathology, 59
L. Ding, Zhe Lu, Q. Lu, Yan-hua Chen (2013)
The claudin family of proteins in human malignancy : a clinical perspective
A. Hjerpe, V. Ascoli, C. Bedrossian, M. Boon, J. Creaney, B. Davidson, A. Dejmek, K. Dobra, A. Fassina, A. Field, P. Fırat, T. Kamei, Tadao Kobayashi, C. Michael, S. Önder, A. Segal, P. Vielh (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed‐type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of CytopathologyDiagnostic Cytopathology, 43
T. Pereira, R. Saad, Yulin Liu, J. Silverman (2006)
The Diagnosis of Malignancy in Effusion Cytology: A Pattern Recognition ApproachAdvances in Anatomic Pathology, 13
(2008)
Blasig IE: Structure and function of claudins
J. Cho, Ga-Eon Kim, J. Lee, Jae Lee, J. Nam, Chan Choi (2013)
Diagnostic Usefulness of MUC1 and MUC4 for Distinguishing between Metastatic Adenocarcinoma Cells and Reactive Mesothelial Cells in Effusion Cell BlocksActa Cytologica, 57
E. Schneeberger, R. Lynch (2004)
The tight junction: a multifunctional complex.American journal of physiology. Cell physiology, 286 6
Xue-ying Su, Gan‐di Li, Wei-ping Liu, B. Xie, Ying Jiang (2011)
Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistryDiagnostic Cytopathology, 39
S. Chowdhuri, P. Fetsch, J. Squires, E. Kohn, A. Filie (2014)
Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: A case report with brief review of immunomarkersDiagnostic Cytopathology, 42
L. Kleinberg, A. Holth, E. Fridman, I. Schwartz, I. Shih, B. Davidson (2007)
The diagnostic role of claudins in serous effusions.American journal of clinical pathology, 127 6
Abderrahman Ouban, Atif Ahmed (2010)
Claudins in human cancer: a review.Histology and histopathology, 25 1
M. Furuse, H. Sasaki, S. Tsukita (1999)
Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction StrandsThe Journal of Cell Biology, 147
Kyle Hewitt, Rachana Agarwal, Patrice Morin (2006)
The claudin gene family: expression in normal and neoplastic tissuesBMC Cancer, 6
Noushin Moghaddam, Mitra Heidarpour, S. Dashti (2014)
Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: Does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells?Advanced Biomedical Research, 3
N. Ordóñez (2013)
Value of claudin-4 immunostaining in the diagnosis of mesothelioma.American journal of clinical pathology, 139 5
K. Ikeda, G. Tate, Takao Suzuki, T. Kitamura, T. Mitsuya (2011)
Diagnostic usefulness of EMA, IMP3, and GLUT‐1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparationsDiagnostic Cytopathology, 39
H. Saleh, M. El-Fakharany, H. Makki, Ahmad Kadhim, S. Masood (2009)
Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: The utility of immunocytochemical panel in the differential diagnosisDiagnostic Cytopathology, 37
G. Krause, L. Winkler, S. Mueller, R. Haseloff, J. Piontek, I. Blasig (2008)
Structure and function of claudins.Biochimica et biophysica acta, 1778 3
Objective: Claudin-3 and claudin-4 have recently been reported as promising targets for the detection and diagnosis of cancer. This study was designed to evaluate the diagnostic value of claudin-3 and claudin-4 immunoreactivity to distinguish metastatic adenocarcinoma cells (MAC) from reactive mesothelial cells (RMC) in effusions. Study Design: Claudin-3 and claudin-4 immunocytochemical staining was performed on 234 cell block specimens, including 194 malignant effusions with MAC and 40 benign effusions with RMC. Any degree of membranous staining was considered positive. Results: Claudin-3 was positive in 190 (97.9%) out of 194 cases with MAC and in 3 (7.5%) out of 40 cases with RMC. Claudin-4 immunoreactivity was seen in all 194 (100%) cases with MAC and in 11 (27.5%) out of 40 cases with RMC. In all claudin-3- or claudin-4-positive RMC samples, the area of positive staining was <25% of the cells. Claudin-3 and claudin-4 efficiently discriminated between MAC and RMC (p < 0.001 for both), and claudin-3 was more specific than claudin-4 in differentiating between MAC and RMC (p < 0.05). Conclusion: These results suggest that claudin-3 and claudin-4 are good candidates to be included as MAC markers in the panel of antibodies to distinguish MAC from RMC in effusion specimens.
Acta Cytologica – Karger
Published: Jan 1, 2016
Keywords: Mesothelial cells; Adenocarcinoma; Body fluids; Claudin-3; Claudin-4; Immunocytochemistry
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.